About Us

Scientific Advisory Board

05/05/2009 21:00:00


Michael L. Klein

Professor Michael L. Klein

Department of Chemistry,
University of Pennsylvania


Philadelphia, Pennsylvania 19104-6323, USA
Email: klein@lrsm.upenn.edu

Michael L. Kleinbegan his independent research career in Canada at the National Research Council, where he remained for 19 years. In 1987 he moved to the University of Pennsylvania where he is the Hepburn Professor of Physical Science and Director of the Centre for Molecular Modeling. In 1993 he was appointed (and is currently) Director of the Laboratory for Research on the Structure of Matter, one of the premier materials research laboratories in the USA.

Klein’s research deals with the application of computation to problems that lie at the interface between chemistry, physics and biology. He has contributed broadly to the methodologies that have enabled simulations to be become an equal partner with experiment in advancing the frontiers of chemical physics, biophysics, materials research and chemical biology.

He has contributed over 580 refereed publications and given hundreds of endowed and invited lectures around the world, including the Linnett Lectures at Cambridge, the Hinshelwood Lectures at Oxford and C.N.R. Rao Award Lecture (India).

He is a Fellow of the Royal Society of London, the Royal Society of Canada, and the American Academy of Arts & Sciences, as well as an honorary Fellow of the Academy of the Developing World (TWAS), Academy of Sciences, Bangalore, Mongolian Academy of Sciences, American Physical Society, Institute of Physics (UK), Chemical Institute (Canada), Chemical Research Society (India), Materials Research Society (India) and the Academie Europeene des Arts et des Lettres.

He has received the American Physical Society Aneesur Rahman Award for Computational Physics, the European Physical Society CECAM Prize for Computational Science and the American Chemical Society Peter Debye Award for Physical Chemistry. He serves on the editorial boards of several international journals and a number of scientific advisory boards. He is a co-founder of PolyMedix and InfluMedix.

Back